CARsgen Therapeutics Holdings (HKSE:02171) FCF Margin %: -58.86% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02171 CARsgen Therapeutics Holdings Ltd HKSE:02171
32 GF Score
Price HK$14.90
! 3 Warning Signs
View Full Analysis

What is CARsgen Therapeutics Holdings FCF Margin %?

CARsgen Therapeutics Holdings HKSE:02171 +1.36% 32 FCF Margin % is -58.86% as of Dec. 2025. GuruFocus rates HKSE:02171 with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 957 Biotechnology companies, CARsgen Therapeutics Holdings ranks worse than 60.92% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CARsgen Therapeutics Holdings's Free Cash Flow for the six months ended in Dec. 2025 was HK$-48.6 Mil. CARsgen Therapeutics Holdings's Revenue for the six months ended in Dec. 2025 was HK$82.5 Mil. Therefore, CARsgen Therapeutics Holdings's FCF Margin % for the quarter that ended in Dec. 2025 was -58.86%.

As of today, CARsgen Therapeutics Holdings's current FCF Yield % is -3.13%.

The historical rank and industry rank for CARsgen Therapeutics Holdings's FCF Margin % or its related term are showing as below:

HKSE:02171' s FCF Margin % Range Over the Past 10 Years
Min: -2676.09   Med: -1088.81   Max: -192.55
Current: -192.55

During the past 7 years, the highest FCF Margin % of CARsgen Therapeutics Holdings was -192.55%. The lowest was -2676.09%. And the median was -1088.81%.

HKSE:02171's FCF Margin % is ranked worse than
60.92% of 957 companies
in the Biotechnology industry
Industry Median: -78.14 vs HKSE:02171: -192.55

CARsgen Therapeutics Holdings FCF Margin % Related Terms

CARsgen Therapeutics Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for CARsgen Therapeutics Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARsgen Therapeutics Holdings FCF Margin % Chart

CARsgen Therapeutics Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -2,676.09 0.00 0.00 -1,088.81 -193.40

CARsgen Therapeutics Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -4,126.12 -506.81 -390.61 -58.86

HKSE:02171 vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, CARsgen Therapeutics Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CARsgen Therapeutics Holdings FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CARsgen Therapeutics Holdings's FCF Margin % falls into.


HKSE:02171
32GF Score
CARsgen Therapeutics Holdings Ltd HKSE:02171
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARsgen Therapeutics Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CARsgen Therapeutics Holdings's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-268.479/138.822
=-193.40 %

CARsgen Therapeutics Holdings's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-48.575/82.524
=-58.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -58.86% mean?
CARsgen Therapeutics Holdings (HKSE:02171) has a FCF Margin % of -58.86% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CARsgen Therapeutics Holdings and its competitors. According to the industry distribution chart, CARsgen Therapeutics Holdings ranks #583 out of 957 companies in the Biotechnology industry, placing it in the top 60.9%.
Is CARsgen Therapeutics Holdings' FCF Margin % too high?
CARsgen Therapeutics Holdings' current FCF Margin % is -58.86%. Based on the distribution chart, CARsgen Therapeutics Holdings ranks #583 out of 957 companies in the Biotechnology industry, which is below the industry midpoint. Overall, CARsgen Therapeutics Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does CARsgen Therapeutics Holdings' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CARsgen Therapeutics Holdings ranks #583 out of 957 companies for FCF Margin %. This places CARsgen Therapeutics Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CARsgen Therapeutics Holdings and its competitors. CARsgen Therapeutics Holdings's current FCF Margin % is -58.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARsgen Therapeutics Holdings stock overvalued right now?
CARsgen Therapeutics Holdings (HKSE:02171) has a current FCF Margin % of -58.86%. The current FCF Margin % is -58.86%. CARsgen Therapeutics Holdings' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CARsgen Therapeutics Holdings (HKSE:02171), the current FCF Margin % is -58.86% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CARsgen Therapeutics Holdings Business Description

Other Exchanges CRTHF:USA
Address No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
32GF Score

Get the complete analysis for HKSE:02171

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$14.90
Price